» Articles » PMID: 22878939

Prevalence of Type 2 Diabetes in Germany in 2040: Estimates from an Epidemiological Model

Overview
Journal Eur J Epidemiol
Specialty Public Health
Date 2012 Aug 11
PMID 22878939
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

To estimate the number of persons in the age-group 55-74 years with type 2 diabetes in Germany until 2040 and to analyze the impact of an intervention in a high risk group. A Markov model is used to generate forecasts by age and sex in each year using inputs of estimated diabetes prevalence, incidence and mortality based on actual national data. Projections about future demographics stem from the German Federal Office of Statistics. In a slightly modified model a state for persons with prediabetes is included to study the interplay of effect-size and participation quote on the number of persons with diabetes. The projected number of people with type 2 diabetes aged 55-74 years rises from 2.4 million in 2010 to 3.9 million in 2030. From 2030 on this number will decrease slightly to 3.3 million in 2040. If every second person aged 55-74 with prediabetes took part in a prevention program with the effect size of the Finnish Diabetes Prevention Program, 0.4 million cases could be prevented until 2030. To prevent 1.0 million cases in 2030, 90 % of all persons with prediabetes had to take part in an intervention that reduces the transition rate from prediabetes to diabetes by 55 %. Unless enormous efforts are spent into prevention programs, the number of persons with type 2 diabetes will increase tremendously in the next two decades.

Citing Articles

How the European Union legislations are tackling the burden of diabetes mellitus: A legal surveillance study.

Mahrouseh N, Lovas S, Njuguna D, Nellamkuzhi N, Andrade C, Sackey W Front Public Health. 2022; 10:1002265.

PMID: 36504978 PMC: 9727193. DOI: 10.3389/fpubh.2022.1002265.


Future prevalence of type 2 diabetes-A comparative analysis of chronic disease projection methods.

Voeltz D, Tonnies T, Brinks R, Hoyer A PLoS One. 2022; 17(3):e0264739.

PMID: 35255104 PMC: 8901066. DOI: 10.1371/journal.pone.0264739.


Secondary data in diabetes surveillance - co-operation projects and definition of references on the documented prevalence of diabetes.

Schmidt C, Heidemann C, Rommel A, Brinks R, Claessen H, Dress J J Health Monit. 2022; 4(2):50-63.

PMID: 35146247 PMC: 8822244. DOI: 10.25646/5988.


Healing, surviving, or dying? - projecting the German future disease burden using a Markov illness-death model.

Milan V, Fetzer S, Hagist C BMC Public Health. 2021; 21(1):123.

PMID: 33430836 PMC: 7799167. DOI: 10.1186/s12889-020-09941-6.


Employment of Telemedicine in Nursing Homes: Clinical Requirement Analysis, System Development and First Test Results.

Ohligs M, Stocklassa S, Rossaint R, Czaplik M, Follmann A Clin Interv Aging. 2020; 15:1427-1437.

PMID: 32884251 PMC: 7443448. DOI: 10.2147/CIA.S260098.


References
1.
Danaei G, Finucane M, Lu Y, Singh G, Cowan M, Paciorek C . National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet. 2011; 378(9785):31-40. DOI: 10.1016/S0140-6736(11)60679-X. View

2.
Evans J, Barnett K, Ogston S, Morris A . Increasing prevalence of type 2 diabetes in a Scottish population: effect of increasing incidence or decreasing mortality?. Diabetologia. 2007; 50(4):729-32. DOI: 10.1007/s00125-006-0585-9. View

3.
Sonnenberg F, Beck J . Markov models in medical decision making: a practical guide. Med Decis Making. 1993; 13(4):322-38. DOI: 10.1177/0272989X9301300409. View

4.
Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson J, Hemio K . Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006; 368(9548):1673-9. DOI: 10.1016/S0140-6736(06)69701-8. View

5.
Schipf S, Werner A, Tamayo T, Holle R, Schunk M, Maier W . Regional differences in the prevalence of known Type 2 diabetes mellitus in 45-74 years old individuals: results from six population-based studies in Germany (DIAB-CORE Consortium). Diabet Med. 2012; 29(7):e88-95. DOI: 10.1111/j.1464-5491.2012.03578.x. View